EP1151119A1 - Method for inhibiting the expression of target genes in plants - Google Patents
Method for inhibiting the expression of target genes in plantsInfo
- Publication number
- EP1151119A1 EP1151119A1 EP00915151A EP00915151A EP1151119A1 EP 1151119 A1 EP1151119 A1 EP 1151119A1 EP 00915151 A EP00915151 A EP 00915151A EP 00915151 A EP00915151 A EP 00915151A EP 1151119 A1 EP1151119 A1 EP 1151119A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- plant
- dna construct
- sequence
- chimeric
- plants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 111
- 230000014509 gene expression Effects 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 31
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 7
- 108020004414 DNA Proteins 0.000 claims abstract description 61
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 32
- 230000004927 fusion Effects 0.000 claims abstract description 20
- 238000013518 transcription Methods 0.000 claims abstract description 19
- 230000035897 transcription Effects 0.000 claims abstract description 19
- 230000027455 binding Effects 0.000 claims abstract description 17
- 239000012634 fragment Substances 0.000 claims abstract description 17
- 230000002103 transcriptional effect Effects 0.000 claims abstract description 13
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims abstract description 12
- 101710096438 DNA-binding protein Proteins 0.000 claims abstract description 11
- 230000009261 transgenic effect Effects 0.000 claims description 47
- 108091023040 Transcription factor Proteins 0.000 claims description 34
- 102000040945 Transcription factor Human genes 0.000 claims description 34
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 15
- 230000004568 DNA-binding Effects 0.000 claims description 11
- 108020001507 fusion proteins Proteins 0.000 claims description 9
- 102000037865 fusion proteins Human genes 0.000 claims description 9
- 239000005556 hormone Substances 0.000 claims description 8
- 229940088597 hormone Drugs 0.000 claims description 8
- 108700026311 Drosophila En Proteins 0.000 claims description 7
- 230000006698 induction Effects 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 7
- 102000005969 steroid hormone receptors Human genes 0.000 claims description 6
- 108020003113 steroid hormone receptors Proteins 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 5
- 238000013519 translation Methods 0.000 claims description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 4
- 102100022940 RE1-silencing transcription factor Human genes 0.000 claims description 4
- 108010049420 RE1-silencing transcription factor Proteins 0.000 claims description 4
- 230000035772 mutation Effects 0.000 claims description 4
- 239000003270 steroid hormone Substances 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 101710185494 Zinc finger protein Proteins 0.000 claims description 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims description 2
- 230000002596 correlated effect Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 239000003862 glucocorticoid Substances 0.000 claims description 2
- 239000000411 inducer Substances 0.000 claims description 2
- 230000030648 nucleus localization Effects 0.000 claims description 2
- 108020003175 receptors Proteins 0.000 claims description 2
- 102000005962 receptors Human genes 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 description 118
- 210000004027 cell Anatomy 0.000 description 33
- 230000006870 function Effects 0.000 description 24
- 241000219194 Arabidopsis Species 0.000 description 13
- 238000013459 approach Methods 0.000 description 13
- 102000009331 Homeodomain Proteins Human genes 0.000 description 11
- 108010048671 Homeodomain Proteins Proteins 0.000 description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 10
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 9
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000009973 maize Nutrition 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 8
- 206010020649 Hyperkeratosis Diseases 0.000 description 8
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 8
- 229960003957 dexamethasone Drugs 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 108700019146 Transgenes Proteins 0.000 description 7
- 230000004075 alteration Effects 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 108700028369 Alleles Proteins 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 230000037430 deletion Effects 0.000 description 6
- 238000012217 deletion Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000000977 initiatory effect Effects 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 5
- 241000219195 Arabidopsis thaliana Species 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000004850 protein–protein interaction Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 235000011331 Brassica Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010021929 Infertility male Diseases 0.000 description 3
- 208000007466 Male Infertility Diseases 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000005014 ectopic expression Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 108091006106 transcriptional activators Proteins 0.000 description 3
- 108020005345 3' Untranslated Regions Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 102000008169 Co-Repressor Proteins Human genes 0.000 description 2
- 108010060434 Co-Repressor Proteins Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 244000289527 Cordyline terminalis Species 0.000 description 2
- 235000009091 Cordyline terminalis Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 208000009869 Neu-Laxova syndrome Diseases 0.000 description 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010034634 Repressor Proteins Proteins 0.000 description 2
- 102000009661 Repressor Proteins Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910002056 binary alloy Inorganic materials 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 230000010307 cell transformation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 230000008124 floral development Effects 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000011890 leaf development Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008121 plant development Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108010016281 ADP-Ribosylation Factor 1 Proteins 0.000 description 1
- 102100034341 ADP-ribosylation factor 1 Human genes 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 101710087860 Auxin response factor 1 Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 101710190853 Cruciferin Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 108010011145 Fushi Tarazu Transcription Factors Proteins 0.000 description 1
- 108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
- 102100033417 Glucocorticoid receptor Human genes 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 108700005087 Homeobox Genes Proteins 0.000 description 1
- 101001006782 Homo sapiens Kinesin-associated protein 3 Proteins 0.000 description 1
- 101000910825 Homo sapiens Protein chibby homolog 1 Proteins 0.000 description 1
- 101000753286 Homo sapiens Transcription intermediary factor 1-beta Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 108010082699 NADPH Oxidase 4 Proteins 0.000 description 1
- 102100021872 NADPH oxidase 4 Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 1
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 102100026774 Protein chibby homolog 1 Human genes 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 101150109434 STM gene Proteins 0.000 description 1
- 101100121642 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GEA1 gene Proteins 0.000 description 1
- 241000277284 Salvelinus fontinalis Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 102100022012 Transcription intermediary factor 1-beta Human genes 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000005652 acute fatty liver of pregnancy Diseases 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000033081 cell fate specification Effects 0.000 description 1
- 230000023715 cellular developmental process Effects 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 108010046929 enhancer-binding protein AP-3 Proteins 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 108010050792 glutenin Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011173 large scale experimental method Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000012223 nuclear import Effects 0.000 description 1
- 230000005937 nuclear translocation Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 230000005080 plant death Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000000063 preceeding effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000037425 regulation of transcription Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012340 reverse transcriptase PCR Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000021217 seedling development Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000006459 vascular development Effects 0.000 description 1
- 230000008511 vegetative development Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
Definitions
- the term "repression domain of the Drosophila engrailed gene (eng)” means a fragment of the Drosophila engrailed gene or of a derivative sequence thereof, said fragment comprising a nucleotide sequence that encodes a polypeptide interfering with the general transcription machinery and transcriptional activators. Said fragment advantageously comprises a minimal repression sequence coding for a polypeptide of 55 residues (Poole et al., 1985, Han K. et al., 1993). The whole engrailed gene may also be used but most preferably without its homeodomain.
- Engrailed related domains which share the same repression activity, may also be used, such as those described in Smith et al. (1996).
- the repressor sequence that is used may be a sequence that codes for at least the Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins (Witzgall et al., 1994) for at least the RE-1- silencing transcription factor (REST) (Thiel et al., 1998), or for at least the BTB (for Broad-complex Tramtrac and Brie) domain, also known as POZ-domain (Ahmad et al., 1998 ; Huynh & Bardwell, 1998).
- KRAB-A Kruppel-associated box-A domain of zinc finger proteins
- REST RE-1- silencing transcription factor
- BTB for Broad-complex Tramtrac and Brie domain
- said transcription factor may preferably be selected from the group consisting of : STM ("Shootmeristemless"), member of the Knotted class of homeodomain proteins, which is an essential gene for development and function of the shoot apical meristem ;
- ZmHox - member of the homeobox proteins more particularly ZmHox 1a/1 b and 2a/2b, which are expressed in maize meristems and proliferating cells from the early embryo to late reproductive organs. This expression pattern suggests a contribution to plant growth and morphogenesis;
- Arabidopsis is a transcription factor belonging the family recently described as ARF1 family for Auxin Response Factor 1 (Ulmasov et al., 1997). Ms41-A analogues may also be used, such as those described in WO 97/23618 or the Arabidopsis gene Monopteros which encodes a transcription factor mediating embryo axis formation and vascular development (Hardtke et al., 1998), and the Arabidopsis gene ETTIN involved in floral development (Sessions, 1997).
- the plants transformed with a chimeric DNA construct of the invention comprising such Ms-41-A factor are expected to be male sterile.
- the promoter that is used is a tissue- specific promoter or a developmentally regulated promoter. This allows a conditional loss of functions that may be desired, for example to design new plant varieties.
- 35S promoter or advantageously the double 35S constitutive promoter of CaMV as described in Kay et al. (1987) ; rice actin promoter followed by the rice actin intron (PAR- IAR) included in plasmid pAct1-F4 as described in Mc Elroy et al. (1991); the constitutive promoter EF-1 ⁇ of the gene encoding for plant elongation factor described in WO 90/02172 or in Axelos et al.
- HMWG promoter High Molecular Weight Glutenin from barley (Anderson et al., 1989) ; the promoter of maize ⁇ zein (P ⁇ zein) included in p ⁇ 63 plasmid in Reina et al. (1990) allowing the expression in albumen of maize seeds ;
- PGEA1 and PGEA6 promoters corresponding to the non coding 5' region of the genes GEA1 and GEA6, expressed in the grains in Arabidopsis thaliana (Gaubier et al., 1993) ; and ⁇ -phaseolin promoter (Riggs et al., 1989). • specific promoters which drive expression in particular plant tissues which are involved in the control of fertility :
- parts of transgenic plants refer in particular to leaves, fruits, seeds, roots or cells that have been genetically transformed.
- the preferred plants that are used for transformation may be for example selected from the group consisting of Arabidopsis thaliana, rice, tobacco, maize, Brassica, wheat, tomato and flowers (Petunia, rose, carnation).
- Figure 5 represents a eng-STM construct.
- Figure 6 represents a eng-AP3 construct.
- the homeodomain of STM was removed in an independent experiment.
- the plasmid pRT ⁇ eng-STM was first partially digested with Hindll, secondly to completion with BamHI and ends were ligated after fill in reaction with Klenow enzyme.
- Plants are regenerated from these callus by modifying the hormonal and osmotic equilibrium of the cells according to the method described by Vain et al, 1989.
- a method of genetic transformation leading to a stable integration of the modified genes in the genome of the plant involves the use of a gene gun.
- the target cells are fragments of callus having a surface area of 10 to 20 mm 2 .
- the fragments are laid in the center of a Petri dish containing a culture medium identical to the initiation medium, further containing 0.2 M of mannitol + 0.2 M of sorbitol (16 fragments per dish). Tissues are then bombarded as previously described.
- the dishes are then sealed using Scellofrais® and cultivated in dark at 27°C.
- the first planting is effected 24 hours afterwards, then every two-weeks during three months in a medium identical to the initiation medium but containing a selective agent.
- the selective agents may be for example active ingredients of herbicidal agents (Basta®, Round up®) or antibiotics (hygromycin, kanamycin).
- Example 5 Expression of the endogenous STM and AP3 genes
- transgenic eng-STM or eng-AP3 phenocopy plants were subjected to RNA gel blot and RT-PCR analysis.
- the chimeric transcripts derived from the CaMV 35S promoter were easily detectable in total or poly(A) + RNA from pooled seedlings or flowers (12 individual progeny) probed with the STM or AP3 coding regions.
- the high abundance of chimeric transcripts interfered with the detection of the shorter native mRNA in these gel blot experiments.
- Discrimination was achieved by probing with the natural 3'UTR sequences that are lacking in the transgenes. The result obtained for the STM 3'UTR confirms transcription of the native STM gene although at a significantly reduced level.
- Example 6 Phenocopies rely on the incorporation of the chimeric eng-STM protein into the nuclear compartment Although the changes in size or identity of the expressing organs might explain the lower transcript levels observed in stm and ap3 phenocopy plants we aimed to elaborate further evidence against homology based gene silencing.
- the chimeric eng-STM polypeptide therefore was expressed in C- terminal fusion with the hormone-binding domain of the glucocorticoid receptor in transgenic Arabidopsis plants. Due to this addition the resulting eng-STM-GR polypeptide should be cytoplasmatic and incorporated into the nuclear compartment only after hormone application. A linkage between the dexamethasone treatment and alterations in SAM activity thus should depend on the nuclear import of the chimeric eng-STM-GR protein and be incompatible with cosuppression.
Abstract
This invention concerns a method for inhibiting the expression of target genes in plants wherein a chimeric DNA construct comprising at least one repressor sequence in transcriptional fusion with at least one plant-specific sequence that codes for a protein or fragment thereof that bind to DNA or that activates transcription either by binding to DNA itself or by interacting with a DNA-binding protein.
Description
A method for inhibiting the expression of target genes in plants
The present invention relates to a method for inhibiting the expression of target genes in plants and to DNA constructs used to implement this method.
Plant transcription factors mostly belong to gene families containing numerous members. An example how large such families can grow is the myMamily comprised of at least 97 genes in Arabidopsis. Also homeobox and MADS box genes are found in multiple copies comprising several subfamilies in all plant species analyzed so far. In genetic screens for loss of function alleles only few of these genes have been associated with a mutant phenotype. One explanation for numerous silent family members may be genetic redundancy; each gene specific contributions may be subtle or dependent on special conditions. This fraction of silent genes in plant as others genomes provides a major challenge in molecular biology because these are foreseen to oppose a functional analysis also in reverse genetic approaches.
In the transformation of plants, to alter the structure and/or the function of whole plants, it may be desirable to block the expression of genes. This may be effected by altering either the sequence of the gene itself or of the transcriptional factor that controls its transcription. For that purpose the antisense technology, as described for example in the US patent 4,943,674, may be used. Site-directed mutagenesis may alternatively be used. It has for example been proposed to use in vitro altered transcriptional activators encoding proteins that bind to one or more components of the transcription complex in such a way that they competitively inhibit expression of target gene or genes in plants (EP 0475 584). Co-suppression system may also be used to block expression of specific genes (Flavell R.B., 1994).
However these technologies require an accurate knowledge of the structure of the gene or of the transcriptional factor (namely of the DNA binding and transactivator domains) to allow the antisense sequence to specifically hybridize with the gene sequence, or to allow the mutation to only
affect some properties of the protein (DNA binding or activator domain) respectively.
Other limitations of these methods are well known by one skilled in the art : in the case of redundancy in genes and/or functions, other related genes, non altered by these targeted technologies, conceal the expression of the target gene. As a result, the observed phenotype is wild-type instead of mutant as expected. Furthermore these techniques make the isolation of new genes, or the determination of new functions difficult, sometimes impossible.
The authors of the present invention now propose an alternative approach for blocking the expression of genes in plants which meets the above requirements and presents other advantages. The method of the invention distinguishes from previous technologies in that this is, as further described, a dominant approach with high penetrance. This method is independent from any DNA sequence homology with the targeted gene, which is crucial for antisense and cosuppression approaches, and moreover circumvents the problem of redundancy in genes and/or functions.
The method of the invention involves the use of a chimeric DNA construct comprising at least one repressor sequence in transcriptional fusion with at least one plant-specific sequence that codes for a protein or fragment thereof that bind to DNA or that activates transcription either by binding to DNA itself or by interacting with a DNA-binding protein ; said repressor sequence being operably linked to elements allowing the transcription of said fused sequences.
The term "plant-specific sequence" means a sequence that originates from plants or has been modified (or shown) to function in plants, i.e. to actually bind to DNA in plants or to activate transcription either by binding to DNA itself or by interacting with a DNA-binding protein.
It is understood that the repressor sequence of said chimeric DNA construct preferably does not contain a sequence that codes for a second other DNA-binding domain, so that no undesirable interaction could occur.
In a preferred embodiment, said repressor sequence is at least the repressor domain of the Drosophila engrailed gene (eng).
The product of the Drosophila engrailed (eng) locus was shown to be involved in the regulatory interactions that govern early embryogenesis (Poole et al, 1985). Eng is a homeodomain-containing transcription factor that is required for cell fate specification through out development of the fly. A pioneering experiment was performed in Drosophila where the DNA-binding homeodomain of the engrailed (eng) gene was replaced by its Fushi tarazu (Ftz) counterpart, and expression of the chimeric gene controlled by heat shock promoter. After induction, the sequence specificity of the Ftz homeodomain directed the strong transcriptional eng repressor function to Ftz target genes resulting in phenocopies of Ftz loss of function alleles in transgenic progeny (John et al., 1995). Thus, the Eng protein was shown to be an active repressor in Drosophilia (John et al, 1995) and cultured animal cells (Han & Manley, 1993). In 1996, Conlon et al use an approach in which the DNA-binding domain of a transcription activator is fused to the engrailed repressor domain to assist in the analysis of Xenopus and Zebrafish transcription factors (Conlon et al, 1996). But no stable transformation has been carried out until now in plants, in order to obtain transgenic plants with heritable mutant phenotype.
According to the present invention, the term "repression domain of the Drosophila engrailed gene (eng)" means a fragment of the Drosophila engrailed gene or of a derivative sequence thereof, said fragment comprising a nucleotide sequence that encodes a polypeptide interfering with the general transcription machinery and transcriptional activators. Said fragment advantageously comprises a minimal repression sequence coding for a polypeptide of 55 residues (Poole et al., 1985, Han K. et al., 1993). The whole engrailed gene may also be used but most preferably without its homeodomain.
"A derivative sequence" is understood as meaning a sequence which differs from the sequence of the Drosophila engrailed gene by mutation, insertion, deletion or substitution of one or more bases, or by the degeneracy of the genetic code so long as it codes for a polypeptide which is substantially the same as the Engrailed product.
Engrailed related domains, which share the same repression activity, may also be used, such as those described in Smith et al. (1996).
In another embodiment, the repressor sequence that is used may be a sequence that codes for at least the Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins (Witzgall et al., 1994) for at least the RE-1- silencing transcription factor (REST) (Thiel et al., 1998), or for at least the BTB (for Broad-complex Tramtrac and Brie) domain, also known as POZ-domain (Ahmad et al., 1998 ; Huynh & Bardwell, 1998).
Chimeric DNA constructs further comprising corepressor sequences associated with said repressor sequence are also encompassed. Among the corepressors of interest, one may cite KAP-1 (Friedman et al.,
1996), groucho (Tolkunova et al., 1998), or KOX-1 (Moosmann et al., 1997), or
N-Cor and SMRT (Huynd and Bardwell, 1998).
In one embodiment, said repressor sequence is fused to a plant- specific sequence that encodes a DNA-binding protein domain. The term "DNA binding protein domain" refers to the whole protein that contains such a DNA- binding domain but also to parts of it independently of their ability to bind to DNA.
In a preferred embodiment, a plant transcription factor, or a DNA- binding fragment thereof, is used as the DNA-binding domain containing protein. A complete transcription factor is preferably used, as it preserves interactions between proteins involved in regulation of transcription.
In an alternative embodiment, the repressor sequence is fused to a sequence that codes for a protein or parts thereof that activates transcription by binding to a DNA-binding protein such as a transcription factor. Such proteins may either increase the affinity of DNA-binding proteins to their target sites or mediate signalling to the transcriptional initiation complex and are generally called coactivators.
In the preferred embodiment wherein the DNA-binding domain containing protein is a plant transcription factor, said transcription factor may preferably be selected from the group consisting of :
STM ("Shootmeristemless"), member of the Knotted class of homeodomain proteins, which is an essential gene for development and function of the shoot apical meristem ;
AP3 ("APETALA3"), member of the MADS box proteins, which is a floral organ identity B function gene essential for the development of petals and stamen. AP3 protein is known to form heterodimers with the PISTILLATA (PI) gene product.
STM and AP3 encode plant transcription factors with well-characterized loss of function alleles. Both genes are not only members of different classes of plant transcription factors but deficiencies in both genes cause phenotypic effects at different developmental stages, early in the vegetative phase or rather late in the floral development.
ZmHox - member of the homeobox proteins, more particularly ZmHox 1a/1 b and 2a/2b, which are expressed in maize meristems and proliferating cells from the early embryo to late reproductive organs. This expression pattern suggests a contribution to plant growth and morphogenesis;
Ms-41-A and Zm-41-A. These two factors are associated with male fertility. Recent results assertain that Ms41-A protein from
Arabidopsis is a transcription factor belonging the family recently described as ARF1 family for Auxin Response Factor 1 (Ulmasov et al., 1997). Ms41-A analogues may also be used, such as those described in WO 97/23618 or the Arabidopsis gene Monopteros which encodes a transcription factor mediating embryo axis formation and vascular development (Hardtke et al., 1998), and the Arabidopsis gene ETTIN involved in floral development (Sessions, 1997). The plants transformed with a chimeric DNA construct of the invention comprising such Ms-41-A factor are expected to be male sterile.
In one embodiment, the chimeric DNA construct of the invention may further comprise a sequence that encodes at least the hormone-binding domain of a steroid hormone receptor, said sequence being in frame with the fusion construct consisting of at least one repressor sequence in transcriptional fusion with at least one plant-specific sequence that codes for a protein or
fragment thereof that activates transcription either by binding to DNA itself or by interacting with a DNA-binding protein ; whereby the nuclear localization of the chimeric protein, that is the product of the translation of said fusion construct is dependent on the application of said steroid hormone or analogues thereof.
The steroid hormone receptor that is used may be for example the glycocorticoid receptor (GR). In that case, dexamethasone may be used to induce the nuclear translocation of the chimeric protein.
Optionally, we can use the amino acid sequences which, when included in a protein, function to promote transport of the protein to the nucleus are known in the art and are termed nuclear localization signals (NLS).
The repression domain of the Drosophila engrailed gene (eng) is operably linked to elements allowing its expression. Such elements may more particularly comprise a promoter and polyadenylation signals.
In one embodiment, the promoter that is used is a constitutive promoter.
In another embodiment, the promoter that is used is a tissue- specific promoter or a developmentally regulated promoter. This allows a conditional loss of functions that may be desired, for example to design new plant varieties.
In still other embodiments, the promoter that is used is an inducible promoter.
The polyadenylation that can be used may be for example the 35S polyA terminator of cauliflower mosaic virus (CaMV), as disclosed in
Franck et al. (1980) and NOS polyA terminator, that corresponds to the non coding 3' region of nopalin synthase of Ti plasmid of Agrobacterium tumefaciens (Depicker et al., 1982).
Among the preferred promoters that can be used, one can cite for example : a) constitutive promoters :
35S promoter, or advantageously the double 35S constitutive promoter of CaMV as described in Kay et al. (1987) ;
rice actin promoter followed by the rice actin intron (PAR- IAR) included in plasmid pAct1-F4 as described in Mc Elroy et al. (1991); the constitutive promoter EF-1α of the gene encoding for plant elongation factor described in WO 90/02172 or in Axelos et al. (1989); - chimeric superpromoter PSP (Ni et al., 1995) constituted by the fusion of a triple repeat of the transcriptional activity element from the promoter of the gene of Agrobacterium tumefaciens octopin syntase, the transcriptional activating element of the promoter of the gene Agrobacterium tumefaciens mannopin synthase ; and - ubiquitin promoter from sunflower (Binet et al., 1991).
b) specific promoters :
• seed-specific promoters :
PCRU promoter of radish cruciferin gene allowing the expression specifically in seeds, as described in Depigny-This et al. (1992) ;
HMWG promoter (High Molecular Weight Glutenin) from barley (Anderson et al., 1989) ; the promoter of maize γzein (Pγzein) included in pγ63 plasmid in Reina et al. (1990) allowing the expression in albumen of maize seeds ;
PGEA1 and PGEA6 promoters corresponding to the non coding 5' region of the genes GEA1 and GEA6, expressed in the grains in Arabidopsis thaliana (Gaubier et al., 1993) ; and β-phaseolin promoter (Riggs et al., 1989). • specific promoters which drive expression in particular plant tissues which are involved in the control of fertility :
Among the promoters of interest one may cite the Brassicaceae A3 or A9 promoter described in WO 92 1 1379, the A6 promoter described in WO 93 02197, or TA29, TA26, TA13 promoters described in WO 89 10396 ; the Ms41-A anther-specific promoter described in WO 97/23618, which may also be used in male sterility systems ;
a dehiscence-zone specific promoter such as the one described in EP 692 030.
c) inducible promoters : a promoter inducible in stress conditions, for example heat shock, wound or interaction with pathogens (Kuhlemeier et al., 1987, WO 94/21793) ; and an ethanol-inducible promoter (Salter et al., 1998) ; and - the PR1a promoter inducible by salicylic acid for example
(US 5,689,044).
The DNA construct of the invention is advantageously inserted in a vector, e.g. a plasmid, for use in plant cell transformation. The transformation of plant cells may be effected by transferring the above vectors in protoplasts, in particular after incubating those protoplasts in a solution of polyethyleneglycol (PEG) in the presence of divalent cations (Ca2+) as described in Krens et al. (1982).
The transformation of plant cells may also be effected by electroporation as described in Fromm et al. (1986).
A gene gun may also be used allowing the projection of metal particles coated with a DNA construct of the invention, whereby genes are delivered into cell nucleus (Sanford et al., 1988).
Another method for transforming plant cells is cytoplasmic or nuclear micro-injection.
In a preferred embodiment, plant cells are transformed with a DNA construct of the invention, by means of a host cell infecting said plant cells. A further subject of the present invention is thus a host cell transformed with a chimeric DNA construct as previously described. Advantageously, the above host cell is Agrobacterium tumefaciens, as used in particular in the methods of Bevan et al. (1984) and An (1986), or Agrobacterium rhizogenes, in particular as used in the method of Jouanin et al. (1987).
Plant cell transformation is preferably effected by transferring the Agrobacterium tumefaciens T region of an extra-chromosomal circular plasmid that induces tumors (Ti) e.g by using a binary system.
For that purpose, two vectors are constructed. In one of these vectors, the T-DNA region is removed by deletion except for the right and left borders, a marker gene being inserted between the two borders to allow the selection in plant cells. The other partner of the binary system is a helper Ti plasmid which is a modified plasmid that has no T-DNA longer but still contains the virulence genes vir, necessary for transforming a plant cell. This plasmid is maintained in Agrobacterium.
The present invention also provides a transgenic plant or parts thereof, said plant being transformed with a DNA construct of the invention, or deriving from a plant initially transformed with a DNA construct of the invention. Such transgenic plants exhibit heritable phenotypes. The term "deriving" refers to plants of the following generations, as long as the parent plant is fertile.
The term "parts" of transgenic plants refer in particular to leaves, fruits, seeds, roots or cells that have been genetically transformed.
The preferred plants that are used for transformation may be for example selected from the group consisting of Arabidopsis thaliana, rice, tobacco, maize, Brassica, wheat, tomato and flowers (Petunia, rose, carnation).
The present invention thus provides a method for obtaining a transgenic plant, wherein a DNA construct of the invention is transferred and expressed in a plant cell and said cell is cultured under conditions for regenerating a whole transgenic plant.
The conditions for regenerating a whole plant from a plant cell are well-known by one skilled in the art.
A chimeric DNA construct of the invention may be used for inhibiting the expression of a target gene in the genome of a plant, the transcription of which involves a DNA-binding protein domain as previously defined.
Inhibiting the expression of a target gene in the genome of a plant may be desired in many purposes. Many transcription factors known by the man skilled in the art play a role in the control of metabolic pathways (starch, lipids, amino acids...) or are involved in the plant development, or in the plant sensibility to pathogen. For example, blocking a gene whose expression is necessary for pollen or another formation (e.g. the Ms-41-A transcription factor, as above described) produces male sterility. Blocking the gene controlled by the AP-3 transcription factor also leads to male sterility. As another example, blocking the gene which codes for the enzyme which catalyses the conversion of sugars to starch can be used to produced sweet corn (see EP 475 584).
It is also possible to obtain transgenic plants with enriched content in lysine by using, according to the invention, the opaque 2 transcription factor (Schmidt et al., 1990), involved in the control of the expression of certain zeins. One could further use Myb-related transcription factors involved in the control of anthocyanin biosynthesis in flowers (Martin et al., 1991 ; Matin, 1997), to modify their colour. Use of other members of Myb- related transcription factors playing a role in the regulation of phenylpropanoid and lignin biosynthesis (Tamagnone et al., 1998) could also be interesting. Some others could be involved in cellular development and senescence.
The chimeric construct, fusion of the repressor domain to the plant transcription factor or part of it, can be advantageously used to identify essential protein-protein interaction domains and interacting protein partners in planta in transgenic plants. In a preferred embodiment, expression of a chimeric protein comprising the repressor domain in fusion to a plant transcription factor is known to cause a dominant phenocopy. By the deletion of increasing parts of plant sequences encoding the transcription factor and their repression in fusion to the repressor domain in transgenic plants, essential protein domains can be identified. These are DNA-binding domains but also others, like protein-protein interaction domains, if the transcription factor is part of multi-component complex. The method according to the invention is therefore also suitable to study protein-protein interactions in planta.
The chimeric DNA construct of the invention can be used to produce phenocopies of loss of function mutants in genes involved in transcriptional control, by reversing the biological function from activation to repression and by providing chimeric fusion proteins in excess over the endogenous function.
Phenocopy is an artificial (transgenic) situation mimicking a mutant phenotype. The term phenocopy is used by Smith et al. (1996), referring to the original description of John et al. (1995), describing a Ftz loss of function phenotype mimicked by the Eng Ftz chimeric protein.
The phenocopy caused by the expression of the chimeric fusion protein allows to associate a biological function to a given transcription factor or gene involved in transcriptional control.
A chimeric DNA construct of the invention may more particularly be used in a method for determining the function of a transcription factor in plants, comprising the steps of : i) fusing a sequence encoding said transcription factor to a repressor sequence to form a DNA construct as previously defined; ii) transforming plant cells with said DNA construct; iii) culturing the plants obtained from the transformed cells and observing a phenocopy of a mutation correlated with the loss of expression of genes controlled by said transcription factor.
The chimeric DNA construct of the invention allows the production of a cDNA library, said library being useful to isolate new genes controlled by the transcriptional activator as above described.
The present invention thus encompasses a method for identifying new genes in plants comprising the steps of : i) obtaining transgenic plants transformed with a chimeric DNA construct of the invention ; ii) comparing the RNA population from said transgenic plants with the RNA population of a plant that has not been transformed with a chimeric DNA construct of the invention, by amplifying (for example by Polymerase
Chain Reaction in a differential display approach (Liang et al., 1993) the RNAs repressed by expression of the chimeric DNA construct, identified as genes inactive in said transgenic plants but active in the plant that has not been transformed with a chimeric DNA construct of the invention. The plants to be compared should genotypically be as identical as possible. Most preferably, the plants that have not been transformed with a chimeric DNA construct of the invention are transgenic plants transformed with a blank vector.
In a preferred embodiment, the method for identifying new genes in plants comprises the steps of : i) obtaining transgenic plants transformed with a chimeric DNA construct comprising a sequence that encodes at least the hormone- binding domain of a steroid hormone receptor and/or comprising an inducible promoter; ii) submitting said transgenic plants to an induction by means of a steroid hormone or analogues thereof and/or promoter inducer, whereby a phenocopy is created due to the loss of expression of target genes; iii) comparing the RNA populations from said transgenic plants before and shortly after induction, by amplifying (for example by Polymerase
Chain Reaction in a differential display approach (Liang et al., 1993) the RNAs repressed by expression of the chimeric DNA construct, identified as genes active before but inactive after induction.
In a preferred embodiment, a differential display approach associated with the AFLP technique described by Vos et al. (1995) or the PCR- Select System (Clontech) is used.
The preferred embodiment of the method of the invention wherein an inducible system is used advantageously allows to identify direct target genes controlled by the transcriptional factor, at any time during the plant development.
The creation of phenocopies by means of a chimeric DNA construct of the invention presents several other advantages :
Phenocopies are hardly sensitive to genetic redundancy. In contrast to mutagenesis approaches like gene machines where knock outs of single genes only give phenotypes in non-redundant situations, the phenocopy approach is expected to be informative in redundant situations. This may be important for species which are not or not truly diploid (e.g. wheat or maize respectively). Also in many Brassica crops the genome is triplicated relative to Arabidopsis.
The advantage in redundant situations is related to the fact that the phenocopy is caused by the chimeric protein making the method independent from DNA sequence homology, crucial for antisense and cosuppression approaches, which focuses effects to single or few genes (depending on the degree of sequence similarity). The newly created chimeric repressor protein may perform and compete with all kinds of interactions and functions related to the transcription factor fused with the repressor. It thus uses functional protein domains and redundant protein functions that partly or fully compensate for the loss of a single gene product (reduced by antisense or cosuppression) therefore should be also effected by the chimeric repressor protein.
Phenocopies support results obtained in gene machines, where many additional elements in the genome frequently interfere with the conclusive association of a phenotype to a specific insertion.
The phenocopy approach is also helpful in transferring information between species, e.g. from Arabidopsis to Brassica crops or between grass crops (rice, maize, wheat, barley) and in comparing regulatory networks between species. By this way, it is possible to detect similarities and differences between groups of genes regulated by the same transcription factor within several species.
The high penetrance (80 %) and dominance of phenocopies in primary transformants distinguishes this method from lower frequency antisense and cosupression approaches, where a few individual progeny are selected.
The below examples and figures illustrate the invention without limiting its scope in any way.
LEGENDS OF FIGURES
Figure 1 represents a top view into the shoot apical meristem of a young wild-type Arabidopsis seedling. In addition to both cotyledons, it has developed four elaborated leaves plus two additional leaf primordia in the center covering the functional shoot apical meristem.
Figure 2 represents a top view into the shoot apical meristem of
Arabidopsis phenocopy eng-STM of the same age as in figure 1. This phenocopy has two horizontal cotyledones and a single leaf in vertical position.
A functional shoot apical meristem is missing and has presumably been consumed by initiation of the single leaf primordium.
Figure 3 represents a flower of wild-type Arabidopsis thaliana with outermost sepals (green), white petals, yellow stamen and central carpel. Figure 4 represents a flower of Arabidopsis thaliana phenocopy eng-AP3. A single sepal has been removed frontally, two neighbouring normal sepals are slightly displaced left and right to allow insight into the second and third floral whorls. Petals and stamen are obviously replaced by sepaloid organs close to the central carpel and small filamentous structures, one visible at the bottom between the two sepaloid petals.
Figure 5 represents a eng-STM construct. Figure 6 represents a eng-AP3 construct.
EXAMPLES
Example 1 : Construct eng-STM
Creation of pRT Ωeng The cDNA clone that is used is D2B clone as described in Poole et al, 1985. This clone was obtained by inserting a 2 kb EcoRI fragment of the engrailed cDNA in a pEMBL vector. The engrailed cDNA sequence is identical to the data base entry (Genbank Access. M 10017) except for the lack of the 3'
end downstream the EcoRI site gaattc, i.e the lack of the 3' end from nucleotide 2014 included.
From the cDNA clone D2B clone a 929 Bp Aflll-BamHI fragment was isolated and inserted into Notl/BamHI cleaved pRTΩNot-Asc vector. Compatibility of the Notl/Aflll sites was achieved by fill in reaction with Klenow enzyme. The cDNA fragment covers the natural translation start and 298 amino acid residues of the engrailed protein. The BamHI site or a following Xbal site can be used to create translational fusions to proteins of interest.
The construct obtained was pRTΩeng. The pRTΩNot-Asc is described in ϋberlacker et al. (1996). It is a derivative of pRT100 (Tόpfer et al., 1987) and contains the CaMV 35S promoter and a polyA signal of Cabb B.
ENG-STM cloning strategy The sequence of the STM coding region that is used is disclosed in Long et al, 1996 and is identical to the database entry (Genbank - Access U32344).
To fuse the STM coding region to the engrailed repressor domain the frame of the unique Xbal cloning site in pRT Ωeng had to be shifted which was achieved by inserting a GATCTCGA adaptor into the upstream BamHI site, which was destroyed. The STM coding region previously amplified by reverse transcriptase PCR from Arabidopsis RNA with an 5' terminal Xbal (upstream the translation start ATG) was inserted into the Xbal site of the adpted pRT Ωeng. The STM coding sequences used contain a BamHI site immediately preceeding the natural translation stop codon, which was used subsequently to create the c-terminal GR fusion.
ENG-STM without homeodomain (HP)
The homeodomain of STM was removed in an independent experiment. For that purpose, the plasmid pRTΩ eng-STM was first partially digested with Hindll, secondly to completion with BamHI and ends were ligated after fill in reaction with Klenow enzyme. Thus, the construction eng-STM
(ΔHD) was obtained.
Example 2 : Construct eng-AP3
ENG-AP3 cloning strategy
The sequence of the AP3 coding region that is used is disclosed in Jack et al., (1992) and is identical to the data base entry (Genbank - Access - D21125). The AP3 cDNA clone coding region is fused to a myc epitope at its carboxy-terminus. The protein coding region including the myc epitope was amplified by PCR with primers adding terminal BamHI sites. The resulting BamHI fragment was inserted into the BamHI site of pRTΩeng. This construct was designated as pRTΩeng-AP3.
Example 3 : Construct eng-STM-GR
ENG-STM-GR
For fusion of the chimeric eng-STM polypeptide with the GR domain (Lloyd et al, 1994) a Xhol site in front of the TMV Ω leader was converted into a BamHI site The eng-STM coding region was then inserted into pBI-ΔGR (Simon et al., 1996 ; Schena et al., 1991) as a BamHI fragment. The artificial BamHI site (see above) in front of the natural STM STOP codon fuses the eng-STM poypeptide in frame with the GR domain.
Example 4 : Obtention of transgenic plants A - Arabidopsis thaliana
Both constructs, ENG-STM and ENG-AP3, were inserted into pGPTV-Bar Asc (Uberlacker et al., 1996) by use of the Ascl sites flanking the expression cassette and subsequently transferred into Agrobacterium tumefaciens, GV3101. Infiltration of Arabidopsis immature inflorescences followed the protocol of Bechtold et al., (1993) with minor modifications, as follows :
A single A. tumefaciens colony was grown at small scale (5 ml) in liquid YEB medium (5 g beef extract, 5 g saccharose, 1 g yeast extract, 1 g bacto-tryptone, 2 mM MgS0 per liter) at 28° C for 48 hours. From this preculture 0.1 ml each are used to inoculate 4 x 500 ml LB medium (5 g yeast extract, 10 g bacto-tryptone, 10 g NaCI per liter) which are grown with vigorous shaking for 16 hours at 28°C. Bacteria are pelleted at 500 x g and resuspended in infiltration medium (50 g saccharose, 0.2 ml silvet per liter) to OD6oo = 0.8. Twenty plants were infiltrated for each constructs. Immature Arabidopsis inflorescences (ecotype Columbia) are therefore inserted upside down into the bacterial suspension in infiltration medium. Vacuum is produced with an oil pump for 5 minutes and released rapidly, this step is repeated 3 times. Subsequently, plants are transferred to the green house until maturation and seed harvest. Seeds are vernalized and transgenic progeny selected for BASTA (eng/stm-GR; kanamycin) resistance. As shown on Figures 1 to 4, the phenotypes observed upon expression of eng-STM and eng-AP3 are those expected. Transgenic eng-STM plants exhibited abnormalities from the earliest seedling stage on. Compared to wild type (Figure 1), the petiole of this single leaf originates centrally not laterally the petioles of both cotyledons. Exceptionally shoot apical meristem (SAM) activity in eng-STM plants was completely terminated after initiation of a single leaf. Generally, however, subsequent primordia all develop in the same fashion and with accidental timing. These trans-dominant alterations phenocopy weak stm alleles and have been reproduced in various independent large-scale experiments (< 1000 transgenic T1 progeny). Generally stm phenocopies are found in 75 % to 90 % of the primary transformants. Alterations may be subtle early in seedling development but are manifested with increasing numbers of leave primordia until the primary SAM ultimately looses its activity in the vast majority of transgenic eng-STM plants.
Concomitantly or after a short break axillary meristems are activated. The resulting secondary axes exhibit weaker phenotypic alterations and often develop quite normal rosettes. A peculiar feature of these axillary meristems is switching of meristem identity back and force between vegetative and inflorescence state resulting in air-borne rosettes. The numbers of
inflorescence/vegetative cycles may vary between individual transgenic plants and exceptionally cycling may perpetuate to plant death. However, the majority of plants ultimately develop fertile flowers sometimes at terminal position. Other peculiarities are a reduced leaf size, alterations in leaf shape, fused leaves or fasciation of the inflorescence. To confirm heredity of the dominant-negative phenotype progeny of 20 Ti plants exhibiting mild to strong stm phenocopies were analysed in the next generation. BASTA resistant T2 progeny were obtained from 18 Ti plants and phenocopies recovered in 16 families. The strength of phenotypic alterations and absolute numbers of affected progeny varied between different families, a variability presumably related to the expression level of the transgene, which may also account for the failure to recover phenocopies in the two residual families.
In contrast to eng-STM transgenic plants the phenotypic alterations caused by ectopic expression of the eng-AP3 construct were exclusively restricted to the flower. In 70% of the primary transformants, petals were converted to sepals in the second floral whorl and filamentous structures replaced stamens in the third whorl (compare wild type in Figure 3 with transgenic plant in 4). Both homeotic transformations are reminiscent of strong ap3 alleles and indicate that ectopic expression of the chimeric eng-AP3 protein trans-dominantly copies the ap3 loss of function phenotype. Due to the lack of functional stamen those ap3-phenocopy plants required backcrossing, but strictly segregating with the BASTA resistance marker this trans-dominant phenotype was transmitted to the next generation. The flowers from the plants transformed with the eng-AP3 construct are male sterile. In order to identify the chimeric eng-AP3 protein in the cell, one could advantageously use the Myc epitope, which would be helpful to study for example whether the chimeric protein is expressed, whether it is cytoplasmatic or nuclear, whether it forms a heterodimer with the pistilata gene product or whether nuclar import is dependent on pistilata. In summary the ectopic expression of both chimeric constructs, eng-STM and eng-AP3, results in stable, inheritable trans-dominant functions phenocopying stm or ap3 loss of function alleles, respectively. Excess of
chimeric repressor transcription factor fusions can efficiently displace the native gene products from target genes.
Although expressed from a constitutive promoter both chimeric repressors eng-STM and eng-AP3 are obviously recruited by either DNA sequence specificity, protein-protein interactions or both to their natural target genes which are repressed resulting in the phenocopy of the respective loss of function mutant phenotype.
B - Maize
Genetic transformation of maize, whatever the method (electroporation, Agrobacterium, microfibres, particle gun) generally involves the use of an undifferentiated cells in rapid divisions that can still regenerate into a complete plant. This type of cells constitutes the embryogenic callus (of type II) of maize. Such callus is obtained from immature embryos having the genotype HI II or A188 x B73 according to the method and the media described in Dennehey et al, 1994, and may be multiplied and maintained by successive prickings every two-weeks on the initiation medium.
Plants are regenerated from these callus by modifying the hormonal and osmotic equilibrium of the cells according to the method described by Vain et al, 1989.
These plants are then acclimated in greenhouse where they can be crossed or self-pollinated.
A method of genetic transformation leading to a stable integration of the modified genes in the genome of the plant is used. This method involves the use of a gene gun. The target cells are fragments of callus having a surface area of 10 to 20 mm2. Four hours before bombarding, the fragments are laid in the center of a Petri dish containing a culture medium identical to the initiation medium, further containing 0.2 M of mannitol + 0.2 M of sorbitol (16 fragments per dish). Tissues are then bombarded as previously described. The dishes are then sealed using Scellofrais® and cultivated in dark at 27°C. The first planting is effected 24 hours afterwards, then every two-weeks during three months in a medium identical to the initiation medium but containing a selective agent. The
selective agents may be for example active ingredients of herbicidal agents (Basta®, Round up®) or antibiotics (hygromycin, kanamycin).
After three months or sometimes sooner, callus that have not been inhibited by the selected agents, develop. These are usually composed of cells resulting from the division of a cell having integrated in its genome one or more copies of gene of interest. The frequency of obtaining such callus is about 0.8 callus per bombarded dish. Callus are identified, individualized, amplified and cultivated so as to regenerate plants. In order to avoid any interference with non transformed cells, all these steps are effected in culture media that contain the selective agent. The regenerated plants are acclimated and cultivated in the greenhouse were they can be crossed or self-pollinated.
In an other embodiment, the transformation of plants may be carried out with Agrobacterium tumefaciens and immature embryos, as described by Ishida et al., (1996).
Example 5 : Expression of the endogenous STM and AP3 genes
One explanation for these phenocopies might be homology dependent cosuppression mediated by high RNA levels of the transgene. To exclude this, transgenic eng-STM or eng-AP3 phenocopy plants were subjected to RNA gel blot and RT-PCR analysis. The chimeric transcripts derived from the CaMV 35S promoter were easily detectable in total or poly(A)+ RNA from pooled seedlings or flowers (12 individual progeny) probed with the STM or AP3 coding regions. Generally the high abundance of chimeric transcripts interfered with the detection of the shorter native mRNA in these gel blot experiments. Discrimination was achieved by probing with the natural 3'UTR sequences that are lacking in the transgenes. The result obtained for the STM 3'UTR confirms transcription of the native STM gene although at a significantly reduced level.
This reduction is not due to absence of the STM or AP3 transcripts in individual Ti progeny, because the native transcripts could be detected by RT-PCR experiments in each individual phenocopy plant. To
distinguish the native mRNA from the chimeric transcript a forward primers located in the protein coding region of either the STM or the AP3 transcripts was combined with reverse primers residing in both native 3' untranslated regions respectively or in the Cabb-B polyadenylation signal of pRT N ot (ϋberlacker et al., 1996). Single tube RT-PCR experiments with three primer combinations failed to detect the endogenous transcripts because the unique forward primer achieved saturation by excess of the chimeric amplicons. In contrast the predicted PCR products, 456 bp STM and 466 bp AP3, were easily detected with the gene specific primer pairs. We have not tried to quantify these RT-PCR experiments because we wanted only to confirm presence of the native transcript in each transgenic plant, but the amount of amplicon differs between individual phenocopy plants. The level of endogenous gene transcripts is always significantly lower than in wild type, a reduction, however, which coincides with significant morphological changes in the expressing organs. In eng-AP3 transgenic flowers the appropriate organs, petals and stamen, are lacking and converted to sepals or small carpeloid filaments.
Example 6 : Phenocopies rely on the incorporation of the chimeric eng-STM protein into the nuclear compartment Although the changes in size or identity of the expressing organs might explain the lower transcript levels observed in stm and ap3 phenocopy plants we aimed to elaborate further evidence against homology based gene silencing. The chimeric eng-STM polypeptide therefore was expressed in C- terminal fusion with the hormone-binding domain of the glucocorticoid receptor in transgenic Arabidopsis plants. Due to this addition the resulting eng-STM-GR polypeptide should be cytoplasmatic and incorporated into the nuclear compartment only after hormone application. A linkage between the dexamethasone treatment and alterations in SAM activity thus should depend on the nuclear import of the chimeric eng-STM-GR protein and be incompatible with cosuppression.
Some of the primary transformants (Ti) obtained with the eng- STM-GR transgene exhibited weak stm phenocopies. To test for
dexamethasone inducibility we focused on one T2 family with phenotypically normal kanamycine resistant seedlings. After confirming their normal development to the 4-5 leaf stage 10 transgenic seedlings were sprayed with dexamethasone and photographed daily to document the developmental progress. As controls either wild-type plants treated with dexamethasone or untreated transgenic progeny were analysed over the same time interval. In the control plants, 4-6 leaf primordia newly appear within the depicted 6-day interval in these. In contrast after dexamethasone application only a single leaf primordia gets evident in the transgenic eng-STM-GR plants. This result was representative for 7 out of 10 transgenic progeny. The residual three transgenic progeny showed a normal development progress, however, RNA gel blot analysis revealed absence of the chimeric eng-STM-GR transcript, which was detected at high levels in the responsive progeny. These 3 escapes therefore are related to transgene silencing and the temporary arrest in leaf development appeared in strict correlation to the transcriptional activity of the transgene. Dexamethasone inducibility in this family, carrying a single T-DNA insertion is inherited to subsequent generations (up to T4 now). But normal development is confined to heterozygous plants, while homozygous progeny often manifest a weak stm phenocopy late in vegetative development. We take this as an indication that the amount of the chimeric eng-STM-GR protein is not allowed to exceed a threshold level, an assumption also compatible with the few stm phenocopies observed among primary eng-STM-GR transformants.
Presence of the hormone in addition to the temporary arrest in SAM activity effects growth of leaf primordia. Petioles of immature leaves hardly elongated in comparison to control plant, the leaflets in eng-STM-GR plants consequently remain closely attached to the shoot axis. Also retarded is growth of the leaf lamina, which is often associated with leaf curling. Most of these defects in leaf development resemble observations in stm phenocopy plants, where initiated leaves generally grow slowly compared to wild-type plants or unaffected progeny. The only pronounced difference compared to eng-STM transgenic plants is the lack in petiole elongation, which, however, may be a consequence of the C-terminal fusion with the GR hormone-binding
domain. The dexamethasone inducibility strongly favours the assumption that the chimeric eng-STM protein exerts a dominant-negative function internally the plant cell nucleus.
Example 7 : Expression of the C-terminal deletion polypeptide eng-STM (ΔHD)
To further investigate the mechanism transgenic plants were raised expressing the C-terminal deletion polypeptide eng-STM (ΔHD). This deletion protein still spans 296 aa of STM protein sequence including the conserved KNOX (Bϋrglin, 1997) and ELK domains (Kerstetter et al., 1994) but lacks the DNA-binding homeodomain. Transcription of the eng-STM (ΔHD) transgene was confirmed in BASTA resistant progeny by RT-PCR resulting in the predicted 192 bp amplicon (compared to 374 bp for eng-STM). The obtained primary transformants exhibited stm phenocopies in frequency and strength indistinguishable from those observed with the full-length protein. With this construction, the trans-dominant negative function provided by the chimeric eng-STM protein is therefore independent of the DNA-binding activity contributed by the STM homeodomain.
Further results obtained in transgenic Arabidopsis indicate that only 50 amino acids residues of the STM protein are sufficient to mediate stm phenocopies in fusion with the eng N-terminus.
REFERENCES
- Ahmad et al, (1998), Proc. Natl. Acad. Sci. USA, 95, 1213-1218 - An G., (1986), Plant Physiol., 81 , 86-91
- Anderson et al, (1989), T.A.G, 77, 689-700
- Axelos et al, (1989), Mol. Gen. Genet., 219, 106-112
- Bechtold et al, (1993), CR. Acad Science, 316, 1194-1199
- Bevan et al, (1984), Nucleic Acid Research, 12, 8711-8721. - Binet et al, (1991), Plant Science, 79, 87-94
- Bϋrglin, (1997), Nucleic Acids Research, 25, 4173-4180
- Conlon et al, (1996), Development, 122, 2427-2435
- Dennehey et al, (1994), Plant Cell Tissue and Organ Culture, 36, 1-7
- Depicker et al, (1982), J. Mol. Appl. Genet., 1 , 561-573 - Depigny-This et al, (1992), Plant. Mol. Biol., 20, 467-479
- Flavell (1994), Proc. Natl. Acad. Sci. USA, 91 , 3490-3496
- Franck et al, (1980), Cell, 21 , 285-294
- Friedmann et al, (1996), Genes Dev., 10, 2067-2078
- Fromm et al, (1986), Nature, 319, 791-793 - Gaubier et al, (1993), Mol. Gen., 238, 409-418
- Han & Manley, (1993), EMBO J., 12, 2723-2733
- Hardtke et al, (1998), EMBO J., 17, 1405-1411
- Huynh & Bardwell, (1998), Oncogene, 17, 2473-2484
- Ishida et al, (1996), Nature Biotechnology, 14, 745-750 - Jack et al, (1992), Cell, 68, 683-697
- John et al, (1995), Development, 121 , 1801-1813
- Jouanin, (1987), Plant. Sci., 53, 53-63
- Kay, (1987), Science, 236, 1299-1302
- Kerstetter et al, (1994), The Plant Cell, 6, 1877-1887 - Krens et al, (1982), Nature, 296, 72-74
- Kuhlemeier et al, (1987), Ann. Rev. Plant. Physiol., 38, 221-257
- Liang et al, (1993), Nucleic Acids Research, 21 , 3269-3275
- Lloyd et al, (1994), Science, 266, 436-439
- Long et al, (1996), Nature, 379, 66-69
- Martin C. et al, ( 1991), Plant J., 1 , 37-49
- Matin C, (1997), Trends Genet., 13, 67-73
- Mc Elroy, (1991), Mol. Gen. Genet., 231 , 150-160 - Moosmann et al, (1997), Biol. Chem., 378, 669-677
- Ni et al, (1995), Plant J7, 661-676
- Poole et al, (1985), Cell, 40, 37-43
- Reina et al, (1990), Nucleic Acids Research, 18, 6426
- Riggs et al, (1989), Plant Science, 63, 47-57 - Salter et al, (1998), The Plant Journal, 16, 127-132
- Sanford, (1988), Trends in Biotechnology, 6, 299-302
- Schena et al, (1991), Proc. Natl. Acad. Sci. USA, 88, 10421-10425
- Schmidt et al, (1990), Proc. Natl. Acad. Sci. USA, 87, 46-50
- Sessions (1997), Development, 124, 4481-4491 - Simon et al, (1996), Nature, 384, 59-62
- Smith et al, (1996), Development, 122, 3141-3150
- Tamagnone et al, (1998), The Plant Cell, 10, 135-154
- Thiel et al, (1998), J. Biol. Chem., 273, 26891-26899
- Tolkunova et al, (1998), Mol. Cell. Biol., 18, 2804-2814 - Tόpfer et al, (1987), Nucleic Acids Research, 15, 5890
- Llberlacker et al, (1996), Molecular Breeding, 2, 293-295
- Ulmasov et al, (1997), Science, 276, 1865-1868
- Vain et al, (1989), Plant Cell Tissue and Organ Culture, 18, 143-151
- Vain et al, (1989), Journal of Plant Physiology, 135, 537-540 - Vos et al, (1995), Nucleic Acids Research, 23, 4407-4414
- Witzgall et al, (1994), Proc. Natl. Acad. Sci. USA, 91 , 4514-4518
Claims
1. A chimeric DNA construct comprising at least one repressor sequence in transcriptional fusion with at least one plant-specific sequence that codes for a protein or fragment thereof that binds to DNA or that activates transcription either by binding to DNA itself or by interacting with a DNA-binding protein ; said repressor sequence being operably linked to elements allowing the transcription of said fused sequences.
2. A chimeric DNA construct according to claim 1 , wherein said repressor sequence is at least the repressor domain of the Drosophila engrailed gene (eng).
3. A chimeric DNA construct according to claim 1 , wherein said repressor sequence encodes for at least the Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins, or for at least the RE-1 -silencing transcription factor (REST), or for at least the BTB (for Broad-complex Tramtrac and Brie) domain, also known as POZ-domain.
4. A chimeric DNA construct according to any of claims 1 to 3, wherein said plant-specific sequence codes for at least a DNA-binding domain of a plant transcription factor.
5. A chimeric DNA construct according to claim 4, wherein said transcription factor is selected from the group consisting of STM, AP3, ZmHox, Ms-41-A and Zm41-A.
6. A chimeric DNA construct according to any of claims 1 to 3, wherein said plant-specific sequence activates transcription by interacting with a DNA-binding protein.
7. A chimeric DNA construct according to any of claims 1 to 6, further comprising a sequence that encodes at least the hormone-binding domain of a steroid hormone receptor, said sequence being in frame with the fusion construct consisting of at least one repressor sequence in transcriptional fusion with at least one plant-specific sequence that codes for a protein or fragment thereof that activates transcription either by binding to DNA itself or by interacting with a DNA-binding protein ; whereby the nuclear localization of the chimeric protein, that is the product of the translation of said fusion construct is dependent on the application of said steroid hormone or analogues thereof.
8. A chimeric DNA construct according to claim 7, wherein said hormone-binding domain of steroid hormone receptor is the hormone- binding domain of a glycocorticoid receptor.
9. A chimeric DNA construct according to any of claims 1 to 8, wherein the elements allowing the transcription of said repressor sequence comprise a constitutive promoter.
10. A host cell transformed with a DNA construct according to any of claim 1 to 9.
11. A transgenic plant or parts thereof, said plant being transformed with a DNA construct according to any of claims 1 to 9, or deriving from a plant initially transformed with a DNA construct according to any of claims 1 to 9.
12. A method for obtaining a transgenic plant according to any of claims 10 or 11 , wherein a DNA construct according to any of claims 1 to 9 is transferred and expressed in a plant cell and said cell is cultured under conditions for regenerating a whole transgenic plant.
13. Use of a chimeric DNA construct according to any of claims 1 to 9 for inhibiting the expression of a target gene in the genome of a plant, the transcription of which is activated by a protein encoded by a plant-specific sequence as defined in any of claims 1 to 9.
14. A method for determining the function of a transcription factor in plants, comprising the steps of: i) fusing a sequence encoding said transcription factor to a repressor sequence to form a DNA construct as defined in any of claims 4 to 9 ; ii) transforming plant cells with said DNA construct; iii) culturing the plants obtained from the transformed cells and observing a phenocopy of a mutation correlated with the loss of expression of genes controlled by said transcription factor.
15. A method for identifying new genes in plants, comprising the steps of : i) obtaining transgenic plants transformed with a chimeric DNA construct according to any of claims 1 to 6 ; ii) comparing the RNA population from said transgenic plants with the RNA population of a plant that has not been transformed with a chimeric DNA construct according to any of claims 1 to 6, by amplifying the RNAs repressed by expression of the chimeric DNA construct, identified as genes inactive in said transgenic plants obtained in step i) but active in the plant that has not been transformed with a chimeric DNA construct.
16. A method for identifying new genes in plants, comprising the steps of : i) obtaining transgenic plants transformed with a chimeric DNA construct according to claims 7 or 8, comprising a sequence that encodes at least the hormone-binding domain of a steroid hormone receptor, and/or according to claim 9, comprising an inducible promoter ; ii) submitting said transgenic plants to an induction by means of a steroid hormone or analogues thereof and/or promoter inducer, whereby a phenocopy is created due the loss of expression of target genes ; iii) comparing the RNA populations from said transgenic plants before and shortly after induction, by amplifying the RNAs repressed by expression of the chimeric DNA construct, identified as genes active before but inactive after induction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00915151A EP1151119A1 (en) | 1999-02-09 | 2000-02-09 | Method for inhibiting the expression of target genes in plants |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99420030 | 1999-02-09 | ||
| EP99420030 | 1999-02-09 | ||
| PCT/EP2000/001524 WO2000047754A1 (en) | 1999-02-09 | 2000-02-09 | A method for inhibiting the expression of target genes in plants |
| EP00915151A EP1151119A1 (en) | 1999-02-09 | 2000-02-09 | Method for inhibiting the expression of target genes in plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1151119A1 true EP1151119A1 (en) | 2001-11-07 |
Family
ID=8242281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00915151A Withdrawn EP1151119A1 (en) | 1999-02-09 | 2000-02-09 | Method for inhibiting the expression of target genes in plants |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1151119A1 (en) |
| AU (1) | AU770893B2 (en) |
| CA (1) | CA2359749A1 (en) |
| WO (1) | WO2000047754A1 (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1469010B1 (en) | 2001-12-26 | 2008-11-12 | National Institute of Advanced Industrial Science and Technology | Transcription regulatory gene and peptide |
| AU2003246349B2 (en) | 2002-08-07 | 2011-02-03 | Basf Plant Science Gmbh | Nucleic acid sequences encoding proteins associated with abiotic stress response |
| EP2361977A1 (en) | 2003-04-15 | 2011-08-31 | BASF Plant Science GmbH | Nucleic acid sequences encoding proteins associated with abiotic stress response, and transgenic plant cells transformed with the same |
| JP2005295879A (en) * | 2004-04-09 | 2005-10-27 | Japan Science & Technology Agency | Method for producing plant body having modified morphology of flower, plant body obtained by using the same and utilization thereof |
| JP2005295878A (en) * | 2004-04-09 | 2005-10-27 | Japan Science & Technology Agency | Method for producing plant body having delayed flower bud formation, plant body obtained by using the same and utilization thereof |
| JP2006006248A (en) * | 2004-06-28 | 2006-01-12 | Japan Science & Technology Agency | Method for producing plant body of which leaf morphogenesis is regulated, plant body obtained by using the same and utilization of the same |
| JP2006020607A (en) * | 2004-07-09 | 2006-01-26 | Japan Science & Technology Agency | Method for producing plant body having modified leaf shape, plant body obtained by using the method, and utilization thereof |
| JP2006042730A (en) * | 2004-08-06 | 2006-02-16 | Japan Science & Technology Agency | Method for producing male sterile body of monocotyledon, plant obtained by using the method and use of the plant |
| EP2053057A3 (en) | 2004-09-24 | 2009-07-15 | BASF Plant Science GmbH | Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmantal stress |
| JP2006101827A (en) * | 2004-10-08 | 2006-04-20 | Japan Science & Technology Agency | Method for producing male-sterile transformed plant and the resulting plant, and use thereof |
| JP2006280242A (en) * | 2005-03-31 | 2006-10-19 | Japan Science & Technology Agency | Method for producing perfect sterility plant and plant obtained by the method, and utilization thereof |
| EP2010661A2 (en) | 2006-03-24 | 2009-01-07 | BASF Plant Science GmbH | Proteins associated with abiotic stress response and homologs |
| CA2663959A1 (en) | 2006-10-13 | 2008-04-17 | Basf Plant Science Gmbh | Plants with increased yield |
| CN102770542A (en) | 2007-05-22 | 2012-11-07 | 巴斯夫植物科学有限公司 | Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| AU2008300579B2 (en) | 2007-09-18 | 2014-11-13 | Basf Plant Science Gmbh | Plants with increased yield |
| BRPI0816880A2 (en) | 2007-09-21 | 2015-09-08 | Basf Plant Science Gmbh | methods for producing a higher yielding plant compared with a corresponding wild-type plant, for producing a higher yielding transgenic plant compared with a corresponding unprocessed wild-type plant, for producing an agricultural composition, for identifying a plant with a increased yield, and for increasing the yield of a plant population, isolated nucleic acid molecule, nucleic acid construction, vector, processes for producing a polypeptide, and for identifying a compound, polypeptide, antibody, plant cell nucleus, cell plant material, plant tissue, propagation material, pollen, progeny, harvested material or plant, seed, plant part, transgenic plant, transgenic plant, transgenic plant cell nucleus, transgenic plant cell, plant comprising one or more of such transgenic plant cell nuclei or plant cells, prog emphasis, seed or pollen derived from or produced by a transgenic plant, composition, and use of nucleic acids. |
| AU2008337398B2 (en) | 2007-12-19 | 2014-04-03 | Basf Plant Science Gmbh | Plants with increased yield and/or increased tolerance to environmental stress (IY-BM) |
| CN102016048A (en) | 2008-02-27 | 2011-04-13 | 巴斯夫植物科学有限公司 | Plants with increased yield |
| MX2011001899A (en) | 2008-08-19 | 2011-04-05 | Basf Plant Science Gmbh | Plants with increased yield by increasing or generating one or more activities in a plant or a part thereof. |
| BRPI0919153A2 (en) | 2008-09-23 | 2019-05-07 | Basf Plant Science Gmbh | method for producing a high yielding plant, nucleic acid molecule, nucleic acid construct, vector, process for producing a polypeptide, polypeptide, antibody, plant cell nucleus, plant cell, plant tissue, propagating material, pollen , progeny, material collected, or a plant, or part of a plant, a transgenic plant, process for identifying a compound, method for producing an agricultural composition, composition, use of nucleic acid, and method for identifying a plant with an increased yield, and to increase the yield of a plant population |
| BRPI0919684A2 (en) | 2008-10-23 | 2014-02-04 | Basf Plant Science Gmbh | METHODS FOR PRODUCING A TRANSGENIC CELL, AND AN AGRICULTURAL COMPOSITION, INSULATED NUCLEIC ACID MOLECULATION, NUCLEIC ACID CONSTRUCTION, VECTOR, PRODUCT IDENTIFICATION, NIPLIC ACID POLYPETIPLE VEGETABLE CELL, PROPAGATION MATERIAL, POLLEN, PROGENY, COLLECTED MATERIAL OR A PLANT, TRANSGENIC PLANT, TRANSGENIC PLANT CELL CELL, TRANSGENIC PLANT CELL, PLANT AND CULUS, COMPOSI DECULATION |
| EP2350289A1 (en) | 2008-10-23 | 2011-08-03 | BASF Plant Science GmbH | Plants with increased yield (nue) |
| CA2768331A1 (en) | 2009-07-23 | 2011-01-27 | Basf Plant Science Company Gmbh | Plants with increased yield |
| MX2012005719A (en) | 2009-11-17 | 2012-07-30 | Basf Plant Science Co Gmbh | Plants with increased yield. |
| WO2014134567A1 (en) * | 2013-03-01 | 2014-09-04 | The Regents Of The University Of California | Methods and compositions for targeting rna polymerases and non-coding rna biogenesis to specific loci |
| BR112017016789A2 (en) | 2015-02-11 | 2018-05-08 | Basf Se | methods for producing a transgenic plant, for controlling unwanted vegetation and for plant cultivation, nucleic acid molecule, nucleic acid construction, vector, mutated hppd polypeptide, plant cell nucleus, transgenic plant cell nucleus, transgenic plant, use of nucleic acid, useful combination, process for preparing a useful combination and use of a useful combination |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866755A (en) * | 1993-06-14 | 1999-02-02 | Basf Aktiengellschaft | Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
-
2000
- 2000-02-09 CA CA002359749A patent/CA2359749A1/en not_active Abandoned
- 2000-02-09 WO PCT/EP2000/001524 patent/WO2000047754A1/en not_active Application Discontinuation
- 2000-02-09 EP EP00915151A patent/EP1151119A1/en not_active Withdrawn
- 2000-02-09 AU AU36563/00A patent/AU770893B2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0047754A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2359749A1 (en) | 2000-08-17 |
| WO2000047754A1 (en) | 2000-08-17 |
| AU3656300A (en) | 2000-08-29 |
| AU770893B2 (en) | 2004-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU770893B2 (en) | A method for inhibiting the expression of target genes in plants | |
| US6005167A (en) | Male-sterile plants, method for obtaining male-sterile plants and recombinant DNA for use therein | |
| US5977441A (en) | Control of plant gene expression | |
| Southerton et al. | Eucalyptus has a functional equivalent of the Arabidopsis floral meristem identity gene LEAFY | |
| US5723765A (en) | Control of plant gene expression | |
| Payne et al. | Heterologous myb genes distinct from GL1 enhance trichome production when overexpressed in Nicotiana tabacum | |
| Huang et al. | The Arabidopsis ACT11 actin gene is strongly expressed in tissues of the emerging inflorescence, pollen, and developing ovules | |
| US20030126642A1 (en) | Compositions and methods for modulating plant development | |
| HUT73336A (en) | Methods and compositions for controlling plant development | |
| US9587243B2 (en) | Ubiquitin regulatory elements | |
| EP1765058A1 (en) | Nucleic acid molecules and their use in plant male sterility | |
| Schoenbeck et al. | The alfalfa (Medicago sativa) TDY1 gene encodes a mitogen-activated protein kinase homolog | |
| BRPI0011101B1 (en) | Vector, and methods for producing asexual derived embryos, for modifying a plant's regenerative capacity, for producing an apomictic plant, and for selecting a modified plant | |
| US7183109B2 (en) | Embryo preferred promoter and method of using same | |
| US5824872A (en) | A constitutive promoter from tobacco | |
| JP2001524315A (en) | Methods and compositions useful for silent transgene activation | |
| US7112723B2 (en) | Globulin 2 regulatory region and method of using same | |
| WO2000023578A2 (en) | Methods of suppressing flowering in transgenic plants | |
| WO2001031017A2 (en) | Plants with a modified flower and seed development | |
| CA2168617C (en) | Constitutive promoter from tobacco | |
| JP2003092936A (en) | Method for reducing pollen fertility by using gene of tapetal layer specific zinc finger transcription factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010802 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT PAYMENT 20010801;LV PAYMENT 20010801;MK;RO PAYMENT 20010801;SI PAYMENT 20010801 |
|
| 17Q | First examination report despatched |
Effective date: 20030613 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOGEMMA |
|
| 17Q | First examination report despatched |
Effective date: 20030613 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20060901 |